1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 RNA Testing 1.2.3 DNA Testing 1.3 Market by Application 1.3.1 Global Hereditary Cancer Testing Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Breast Cancer 1.3.3 Gastrointestinal Cancer 1.3.4 Prostate Cancer 1.3.5 Respiratory/Lung Cancer 1.3.6 Other Cancers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hereditary Cancer Testing Market Perspective (2017-2028) 2.2 Hereditary Cancer Testing Growth Trends by Region 2.2.1 Hereditary Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hereditary Cancer Testing Historic Market Size by Region (2017-2022) 2.2.3 Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028) 2.3 Hereditary Cancer Testing Market Dynamics 2.3.1 Hereditary Cancer Testing Industry Trends 2.3.2 Hereditary Cancer Testing Market Drivers 2.3.3 Hereditary Cancer Testing Market Challenges 2.3.4 Hereditary Cancer Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hereditary Cancer Testing Players by Revenue 3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2017-2022) 3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2017-2022) 3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue 3.4 Global Hereditary Cancer Testing Market Concentration Ratio 3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2021 3.5 Hereditary Cancer Testing Key Players Head office and Area Served 3.6 Key Players Hereditary Cancer Testing Product Solution and Service 3.7 Date of Enter into Hereditary Cancer Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hereditary Cancer Testing Breakdown Data by Type 4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2017-2022) 4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028) 5 Hereditary Cancer Testing Breakdown Data by Application 5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2017-2022) 5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hereditary Cancer Testing Market Size (2017-2028) 6.2 North America Hereditary Cancer Testing Market Size by Country (2017-2022) 6.3 North America Hereditary Cancer Testing Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Hereditary Cancer Testing Market Size (2017-2028) 7.2 Europe Hereditary Cancer Testing Market Size by Country (2017-2022) 7.3 Europe Hereditary Cancer Testing Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2017-2028) 8.2 Asia-Pacific Hereditary Cancer Testing Market Size by Country (2017-2022) 8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Hereditary Cancer Testing Market Size (2017-2028) 9.2 Latin America Hereditary Cancer Testing Market Size by Country (2017-2022) 9.3 Latin America Hereditary Cancer Testing Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2017-2028) 10.2 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2017-2022) 10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Ambry Genetics (Konica Minota) 11.1.1 Ambry Genetics (Konica Minota) Company Detail 11.1.2 Ambry Genetics (Konica Minota) Business Overview 11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction 11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022) 11.1.5 Ambry Genetics (Konica Minota) Recent Development 11.2 Asper Biogene 11.2.1 Asper Biogene Company Detail 11.2.2 Asper Biogene Business Overview 11.2.3 Asper Biogene Hereditary Cancer Testing Introduction 11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022) 11.2.5 Asper Biogene Recent Development 11.3 Natera 11.3.1 Natera Company Detail 11.3.2 Natera Business Overview 11.3.3 Natera Hereditary Cancer Testing Introduction 11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2017-2022) 11.3.5 Natera Recent Development 11.4 Caris Life Sciences 11.4.1 Caris Life Sciences Company Detail 11.4.2 Caris Life Sciences Business Overview 11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction 11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) 11.4.5 Caris Life Sciences Recent Development 11.5 BioReference Laboratories (GeneDx) 11.5.1 BioReference Laboratories (GeneDx) Company Detail 11.5.2 BioReference Laboratories (GeneDx) Business Overview 11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction 11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022) 11.5.5 BioReference Laboratories (GeneDx) Recent Development 11.6 LabSolutions 11.6.1 LabSolutions Company Detail 11.6.2 LabSolutions Business Overview 11.6.3 LabSolutions Hereditary Cancer Testing Introduction 11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022) 11.6.5 LabSolutions Recent Development 11.7 Progenity，Inc 11.7.1 Progenity，Inc Company Detail 11.7.2 Progenity，Inc Business Overview 11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction 11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022) 11.7.5 Progenity，Inc Recent Development 11.8 ARUP Laboratories 11.8.1 ARUP Laboratories Company Detail 11.8.2 ARUP Laboratories Business Overview 11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction 11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022) 11.8.5 ARUP Laboratories Recent Development 11.9 Myriad 11.9.1 Myriad Company Detail 11.9.2 Myriad Business Overview 11.9.3 Myriad Hereditary Cancer Testing Introduction 11.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2017-2022) 11.9.5 Myriad Recent Development 11.10 NeoGenomics 11.10.1 NeoGenomics Company Detail 11.10.2 NeoGenomics Business Overview 11.10.3 NeoGenomics Hereditary Cancer Testing Introduction 11.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022) 11.10.5 NeoGenomics Recent Development 11.11 Blueprint Genetics 11.11.1 Blueprint Genetics Company Detail 11.11.2 Blueprint Genetics Business Overview 11.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction 11.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) 11.11.5 Blueprint Genetics Recent Development 11.12 CellMax Life 11.12.1 CellMax Life Company Detail 11.12.2 CellMax Life Business Overview 11.12.3 CellMax Life Hereditary Cancer Testing Introduction 11.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022) 11.12.5 CellMax Life Recent Development 11.13 Fulgent Genetics 11.13.1 Fulgent Genetics Company Detail 11.13.2 Fulgent Genetics Business Overview 11.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction 11.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) 11.13.5 Fulgent Genetics Recent Development 11.14 Strand Life Sciences 11.14.1 Strand Life Sciences Company Detail 11.14.2 Strand Life Sciences Business Overview 11.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction 11.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) 11.14.5 Strand Life Sciences Recent Development 11.15 Myogenes 11.15.1 Myogenes Company Detail 11.15.2 Myogenes Business Overview 11.15.3 Myogenes Hereditary Cancer Testing Introduction 11.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022) 11.15.5 Myogenes Recent Development 11.16 LabCorp 11.16.1 LabCorp Company Detail 11.16.2 LabCorp Business Overview 11.16.3 LabCorp Hereditary Cancer Testing Introduction 11.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022) 11.16.5 LabCorp Recent Development 11.17 Quest Diagnostics 11.17.1 Quest Diagnostics Company Detail 11.17.2 Quest Diagnostics Business Overview 11.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction 11.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022) 11.17.5 Quest Diagnostics Recent Development 11.18 Pathway Genomics 11.18.1 Pathway Genomics Company Detail 11.18.2 Pathway Genomics Business Overview 11.18.3 Pathway Genomics Hereditary Cancer Testing Introduction 11.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022) 11.18.5 Pathway Genomics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of RNA Testing Table 3. Key Players of DNA Testing Table 4. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Hereditary Cancer Testing Market Share by Region (2017-2022) Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Hereditary Cancer Testing Market Share by Region (2023-2028) Table 10. Hereditary Cancer Testing Market Trends Table 11. Hereditary Cancer Testing Market Drivers Table 12. Hereditary Cancer Testing Market Challenges Table 13. Hereditary Cancer Testing Market Restraints Table 14. Global Hereditary Cancer Testing Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Hereditary Cancer Testing Market Share by Players (2017-2022) Table 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021) Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hereditary Cancer Testing Product Solution and Service Table 21. Date of Enter into Hereditary Cancer Testing Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2017-2022) Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2023-2028) Table 27. Global Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Hereditary Cancer Testing Revenue Market Share by Application (2017-2022) Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Hereditary Cancer Testing Revenue Market Share by Application (2023-2028) Table 31. North America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million) Table 41. Ambry Genetics (Konica Minota) Company Detail Table 42. Ambry Genetics (Konica Minota) Business Overview Table 43. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product Table 44. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 45. Ambry Genetics (Konica Minota) Recent Development Table 46. Asper Biogene Company Detail Table 47. Asper Biogene Business Overview Table 48. Asper Biogene Hereditary Cancer Testing Product Table 49. Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 50. Asper Biogene Recent Development Table 51. Natera Company Detail Table 52. Natera Business Overview Table 53. Natera Hereditary Cancer Testing Product Table 54. Natera Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 55. Natera Recent Development Table 56. Caris Life Sciences Company Detail Table 57. Caris Life Sciences Business Overview Table 58. Caris Life Sciences Hereditary Cancer Testing Product Table 59. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 60. Caris Life Sciences Recent Development Table 61. BioReference Laboratories (GeneDx) Company Detail Table 62. BioReference Laboratories (GeneDx) Business Overview Table 63. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product Table 64. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 65. BioReference Laboratories (GeneDx) Recent Development Table 66. LabSolutions Company Detail Table 67. LabSolutions Business Overview Table 68. LabSolutions Hereditary Cancer Testing Product Table 69. LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 70. LabSolutions Recent Development Table 71. Progenity，Inc Company Detail Table 72. Progenity，Inc Business Overview Table 73. Progenity，Inc Hereditary Cancer Testing Product Table 74. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 75. Progenity，Inc Recent Development Table 76. ARUP Laboratories Company Detail Table 77. ARUP Laboratories Business Overview Table 78. ARUP Laboratories Hereditary Cancer Testing Product Table 79. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 80. ARUP Laboratories Recent Development Table 81. Myriad Company Detail Table 82. Myriad Business Overview Table 83. Myriad Hereditary Cancer Testing Product Table 84. Myriad Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 85. Myriad Recent Development Table 86. NeoGenomics Company Detail Table 87. NeoGenomics Business Overview Table 88. NeoGenomics Hereditary Cancer Testing Product Table 89. NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 90. NeoGenomics Recent Development Table 91. Blueprint Genetics Company Detail Table 92. Blueprint Genetics Business Overview Table 93. Blueprint Genetics Hereditary Cancer TestingProduct Table 94. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 95. Blueprint Genetics Recent Development Table 96. CellMax Life Company Detail Table 97. CellMax Life Business Overview Table 98. CellMax Life Hereditary Cancer TestingProduct Table 99. CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 100. CellMax Life Recent Development Table 101. Fulgent Genetics Company Detail Table 102. Fulgent Genetics Business Overview Table 103. Fulgent Genetics Hereditary Cancer TestingProduct Table 104. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 105. Fulgent Genetics Recent Development Table 106. Strand Life Sciences Company Detail Table 107. Strand Life Sciences Business Overview Table 108. Strand Life Sciences Hereditary Cancer TestingProduct Table 109. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 110. Strand Life Sciences Recent Development Table 111. Myogenes Company Detail Table 112. Myogenes Business Overview Table 113. Myogenes Hereditary Cancer TestingProduct Table 114. Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 115. Myogenes Recent Development Table 116. LabCorp Company Detail Table 117. LabCorp Business Overview Table 118. LabCorp Hereditary Cancer TestingProduct Table 119. LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 120. LabCorp Recent Development Table 121. Quest Diagnostics Company Detail Table 122. Quest Diagnostics Business Overview Table 123. Quest Diagnostics Hereditary Cancer TestingProduct Table 124. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 125. Quest Diagnostics Recent Development Table 126. Pathway Genomics Company Detail Table 127. Pathway Genomics Business Overview Table 128. Pathway Genomics Hereditary Cancer TestingProduct Table 129. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million) Table 130. Pathway Genomics Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2021 VS 2028 Figure 2. RNA Testing Features Figure 3. DNA Testing Features Figure 4. Global Hereditary Cancer Testing Market Share by Application in 2021 & 2028 Figure 5. Breast Cancer Case Studies Figure 6. Gastrointestinal Cancer Case Studies Figure 7. Prostate Cancer Case Studies Figure 8. Respiratory/Lung Cancer Case Studies Figure 9. Other Cancers Case Studies Figure 10. Hereditary Cancer Testing Report Years Considered Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Hereditary Cancer Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Hereditary Cancer Testing Market Share by Region: 2021 VS 2028 Figure 14. Global Hereditary Cancer Testing Market Share by Players in 2021 Figure 15. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2021 Figure 17. North America Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Hereditary Cancer Testing Market Share by Country (2017-2028) Figure 19. United States Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Hereditary Cancer Testing Market Share by Country (2017-2028) Figure 23. Germany Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Hereditary Cancer Testing Market Share by Region (2017-2028) Figure 31. China Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Hereditary Cancer Testing Market Share by Country (2017-2028) Figure 39. Mexico Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Hereditary Cancer Testing Market Share by Country (2017-2028) Figure 43. Turkey Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 46. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 47. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 48. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 49. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 50. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 51. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 52. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 53. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 54. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 55. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 56. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 57. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 58. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 59. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 60. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 61. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 62. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Ambry Genetics (Konica Minota) Asper Biogene Natera Caris Life Sciences BioReference Laboratories (GeneDx) LabSolutions Progenity，Inc ARUP Laboratories Myriad NeoGenomics Blueprint Genetics CellMax Life Fulgent Genetics Strand Life Sciences Myogenes LabCorp Quest Diagnostics Pathway Genomics